| Original language | English |
|---|---|
| Pages (from-to) | e113-e114 |
| Journal | Diabetes Care |
| Volume | 46 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2023 |
Bibliographical note
Funding Information:SCS for PDN and is a co-investigator for the Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain (SENZA-PDN) trial. S.E. has received consultancy fees from Abbott, Boston Scientific Corp., Mainstay Medical, and Medtronic, all unrelated to this work. He has received department research funding from the National Institute of Health Research, Medtronic, and Nevro Corp. No other potential conflicts of interest relevant to this article were reported.